ChromoTek SARS-CoV-2 Spike Recombinant VHH [NM1230]

Recombinant monovalent Nanobody against the Receptor-binding domain (RBD) of SARS-CoV-2 Spike protein

Specificity

Virus

Applications

BLI, Multiplex ACE2 competition assay

Conjugate

Unconjugated

Cat no : sc-NM1230

Synonyms

SARS-CoV-2, SARS-CoV-2 Spike, Spike



Product Information

Recombinant monovalent Nanobody against the Receptor-binding domain (RBD) of SARS-CoV-2 Spike protein

SpecificityVirus
ClonalityMonoclonal
HostAlpaca, recombinantly produced
ClassRecombinant
Clone No.NM1230 [Wagner et al. EMBO Rep. 2021 May 5;22(5):e52325. PMID: 33904225]
TypeNanobody / VHH, monovalent
RRIDAB_2892255
EpitopeAmino acids 351 and 437-503
ImmunogenRBD of SARS-CoV-2 Spike protein
Full NameSARS-CoV-2 Spike Protein
GenBank Accession NumberNC_045512
Calculated MW25 kDa
Gene SymbolCOVID-19 S Protein
GeneID (NCBI)43740568
Affinity (KD) 9.5 nM
ConjugateUnconjugated
FormLiquid
Purification MethodRecombinant expression, affinity purification by IMAC.
Note: SARS-CoV-2 Spike Recombinant VHH carries a C-terminal Myc-tag and His-tag.
Concentration1000 µg/mL (64.8 µM)
Positive ControlsBLI: biotinylated RBD and SARS-CoV-2 Spike Recombinant VHH
Cited ApplicationsBLI, Multiplex ACE2 competition assay
Note: Not recommended for Western blotting
Storage BufferPBS, 0.09% sodium azide
Safety datasheet (SDS): sodium azide
Storage ConditionAliquot upon receipt and store at -20°C/-4°F. Avoid freeze-thaw cycles.
StabilityStable for 1 year at -20°C/-4°F after shipment.
ShipmentShipped at ambient temperature.